Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank36
3Y CAGR-15.0%
5Y CAGR-16.3%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-15.0%/yr
Annual compound
5Y CAGR
-16.3%/yr
Consistent
Percentile
P36
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.01 | -64.9% |
| 2024 | 0.03 | +197.7% |
| 2023 | -0.03 | -279.2% |
| 2022 | 0.01 | -75.2% |
| 2021 | 0.06 | +168.6% |
| 2020 | 0.02 | -18.0% |
| 2019 | 0.03 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 0.17 | -86.3% |
| 2016 | 1.21 | - |